JIANGXI SYNERGY PHARMACEUTICAL CO., LTD.

Jiangxi Synergy Pharmaceutical Co., Ltd.

300636

CNE100002P83

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 17/07/2024 am IST			5-day change	1st Jan Change
8.86 ^CNY	-0.23%		-5.44%	-15.94%

24/06	Jiangxi Synergy Pharmaceutical Co., Ltd.(XSEC:300636) dropped from S&P Global BMI Index	CI
17/06	Jiangxi Synergy Pharmaceutical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 21 June 2024	CI

Jiangxi Synergy Pharmaceutical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 21 June 2024

June 18, 2024 at 01:02 am IST

Jiangxi Synergy Pharmaceutical Co., Ltd. announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 0.40000000 for the year 2023, payable on 21 June 2024. Record date is 20 June 2024. Ex-date is 21 June 2024.

Latest news about Jiangxi Synergy Pharmaceutical Co., Ltd.

Jiangxi Synergy Pharmaceutical Co., Ltd.(XSEC:300636) dropped from S&P Global BMI Index	24/06	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 21 June 2024	18/06	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Board Appointments	21/05	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Final Cash Dividend for 2023	21/05	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023	25/04	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	24/04	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/23/25	CI
Jiangxi Synergy Pharmaceutical Co., Ltd.(XSEC:300636) added to S&P Global BMI Index	18/23/18	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/23/28	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 24 May 2023	19/23/19	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2022	17/23/17	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Announces Cash Dividend for the Year 2022	25/23/25	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23/23/23	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/22/27	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	26/22/26	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. announced that it expects to receive CNY 1.1 billion in funding	01/22/01	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for 2021, Payable on 05 July 2022	30/22/30	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Final Dividend for 2021	17/22/17	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/22/27	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Proposes Final Dividend for 2021	26/22/26	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	23/22/23	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	28/21/28	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	05/21/05	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Announces Final Cash Dividend for the Year 2020, Payable on May 18, 2021	13/21/13	CI

Chart Jiangxi Synergy Pharmaceutical Co., Ltd.

Duration

Period

Chart Jiangxi Synergy Pharmaceutical Co., Ltd.

More charts

Company Profile

Jiangxi Synergy Pharmaceutical Co Ltd is a pharmaceutical manufacturing company. The Company is engaged in research, development, production and sales of chemical raw materials and pharmaceutical intermediates. The Company's products are used in various types of drugs, including nervous system drugs, such as antiepileptic drugs and antiulcer drugs; non-steroidal anti-inflammatory analgesics; circulatory system drugs, such as antihypertensive drugs; mental disorders drugs, such as antidepressants Medicine; and anti-viral drugs. The company's products are sold to domestic and foreign markets, including Europe, North America and Japan.

Sector

Pharmaceuticals

Calendar

29/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Jiangxi Synergy Pharmaceutical Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

8.86 CNY

Average target price

9.3 CNY

Spread / Average Target

+4.97%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
JIANGXI SYNERGY PHARMACEUTICAL CO., LTD.	-15.94%	510M
ELI LILLY AND COMPANY	+55.35%	815B
NOVO NORDISK A/S	+32.24%	597B
JOHNSON & JOHNSON	-0.10%	377B
MERCK & CO., INC.	+15.47%	319B
ABBVIE INC.	+13.10%	310B
ASTRAZENECA PLC	+16.13%	247B
NOVARTIS AG	+14.29%	228B
AMGEN INC.	+16.54%	180B
PFIZER, INC.	+4.31%	170B

Other Pharmaceuticals